financetom
Business
financetom
/
Business
/
VW workers at Osnabrueck plant hold fresh warning strike
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
VW workers at Osnabrueck plant hold fresh warning strike
Nov 9, 2024 11:10 AM

FRANKFURT (Reuters) - Workers at Volkswagen's Osnabrueck plant, considered a possible target for closure under the German automaker's restructuring plans, are holding fresh warning strikes on Wednesday as part of regional protests over pay, the IG Metall union said.

It is the second time in as many weeks that workers at the site are on strike, reflecting growing tension over Volkswagen's efforts to cut costs and potentially close factories in Germany for the first time.

While strikes at Volkswagen's other western German factories are only possible from December, labour contracts at Osnabrueck are governed differently, making such action possible now.

At around 0930 CET (0830 GMT), workers will start the journey from the plant to the local headquarters of IG Metall, where they will join staff from other local businesses by 1030 CET, the union said.

IG Metall is demanding 7% pay rises compared with an offer from employers' associations of a 3.6% increase over 27 months. Companies say the demands are unrealistic.

Volkswagen's plant in Osnabrueck, which employs around 2,300 staff, manufactures Porsche's Cayman and Boxster models as well as Volkswagen's T-Roc Cabriolet.

But Porsche has announced plans to build the next generations of the Cayman and Boxster at its Stuttgart-Zuffenhausen plant, and Volkswagen will stop production of the T-Roc Cabriolet next year, creating a potential production issue for Osnabrueck.

Last week, Volkswagen works council head Daniela Cavallo said that Porsche management had informed the Osnabrueck plant that it would end their existing business relationship.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Absci, AMD Team up to Advance AI Drug Discovery
Absci, AMD Team up to Advance AI Drug Discovery
Jan 8, 2025
08:02 AM EST, 01/08/2025 (MT Newswires) -- Absci ( ABSI ) said Wednesday it has entered into a strategic collaboration with Advanced Micro Devices ( AMD ) to deploy AMD Instinct accelerators and ROCm software to power AI drug discovery workloads, including Absci's ( ABSI ) advanced de novo antibody design models. As part of the collaboration, Advanced Micro Devices...
OpenAI boss denies sexually assaulting his sister after she files lawsuit
OpenAI boss denies sexually assaulting his sister after she files lawsuit
Jan 8, 2025
LONDON (Reuters) - OpenAI Chief Executive Sam Altman has denied sexually abusing his sister when she was a child, after she filed a lawsuit in the United States accusing him of regularly sexually abusing her between 1997 and 2006. The lawsuit, filed by Ann Altman's lawyers in a U.S. District Court in Missouri, alleges counts of sexual assault and sexual...
BRIEF-Flowers Foods To Acquire Simple Mills
BRIEF-Flowers Foods To Acquire Simple Mills
Jan 8, 2025
Jan 8 (Reuters) - Flowers Foods Inc ( FLO ): * FLOWERS FOODS, INC. ( FLO ) TO ACQUIRE SIMPLE MILLS * FLOWERS FOODS INC ( FLO ) - TO ACQUIRE SIMPLE MILLS FOR $795 MILLION IN CASH * FLOWERS FOODS INC ( FLO ) - SECURES $795 MILLION TERM LOAN FROM RBC * FLOWERS FOODS INC ( FLO )...
Jasper Therapeutics Says Preliminary Study Data for Urticaria Treatment Show Reduced Disease Activity
Jasper Therapeutics Says Preliminary Study Data for Urticaria Treatment Show Reduced Disease Activity
Jan 8, 2025
08:13 AM EST, 01/08/2025 (MT Newswires) -- Jasper Therapeutics ( JSPR ) said Wednesday that preliminary data from an ongoing phase 1b/2a study of subcutaneously administered briquilimab as a treatment for chronic spontaneous urticaria showed substantial reductions in disease activity. The company said the 49-patient study showed clinical responses as early as one week after the first dose as well...
Copyright 2023-2026 - www.financetom.com All Rights Reserved